Your browser doesn't support javascript.
loading
Thrombolytic Agents: Nanocarriers in Controlled Release.
Hassanpour, Soodabeh; Kim, Han-Jun; Saadati, Arezoo; Tebon, Peyton; Xue, Chengbin; van den Dolder, Floor W; Thakor, Jai; Baradaran, Behzad; Mosafer, Jafar; Baghbanzadeh, Amir; de Barros, Natan Roberto; Hashemzaei, Mahmoud; Lee, Kang Ju; Lee, Junmin; Zhang, Shiming; Sun, Wujin; Cho, Hyun-Jong; Ahadian, Samad; Ashammakhi, Nureddin; Dokmeci, Mehmet R; Mokhtarzadeh, Ahad; Khademhosseini, Ali.
Afiliación
  • Hassanpour S; Department of Analytical Chemistry, Faculty of Science, Palacky University Olomouc, 17. Listopadu 12, Olomouc, 77146, Czech Republic.
  • Kim HJ; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • Saadati A; Terasaki Institute for Biomedical Innovation, Los Angeles, CA, 90024, USA.
  • Tebon P; Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, 516614731, Iran.
  • Xue C; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • van den Dolder FW; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • Thakor J; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • Baradaran B; Division Heart and Lungs, Department of Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, GA, 3508, The Netherlands.
  • Mosafer J; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht, CT, 3584, The Netherlands.
  • Baghbanzadeh A; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • de Barros NR; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, 516614731, Iran.
  • Hashemzaei M; Research Center of Advanced Technologies in Medicine, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, 9519633787, Iran.
  • Lee KJ; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, 516614731, Iran.
  • Lee J; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • Zhang S; Department of Pharmacodynamics and Toxicology, School of Pharmacy, Zabol University of Medical Sciences, Zabol, 9861618335, Iran.
  • Sun W; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • Cho HJ; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • Ahadian S; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • Ashammakhi N; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • Dokmeci MR; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
  • Mokhtarzadeh A; College of Pharmacy, Kangwon National University, Chuncheon, Gangwon, 24341, Republic of Korea.
  • Khademhosseini A; Department of Bioengineering, Center for Minimally Invasive Therapeutics (C-MIT) and California NanoSystems Institute University of California-Los Angeles, Los Angeles, CA, 90095, USA.
Small ; 16(40): e2001647, 2020 10.
Article en En | MEDLINE | ID: mdl-32790000

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombosis / Infarto del Miocardio Límite: Humans Idioma: En Revista: Small Asunto de la revista: ENGENHARIA BIOMEDICA Año: 2020 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombosis / Infarto del Miocardio Límite: Humans Idioma: En Revista: Small Asunto de la revista: ENGENHARIA BIOMEDICA Año: 2020 Tipo del documento: Article País de afiliación: República Checa